Fig. 3From: Empagliflozin protects against atherosclerosis progression by modulating lipid profiles and sympathetic activityThe serum levels of IL-1β (A), IL-6 (B), and IL-10 (C) in the sham, AS and EMPA groups. AS, atherosclerosis group; EMPA, empagliflozin group. One-way analysis of variance with the Bonferroni post hoc test was used. n = 6, *P<0.05, ns, not significantBack to article page